Moderna tapped Kenya as the country for its $500 million mRNA vaccine manufacturing push on the African continent. The drugmaker said it inked a memorandum of understanding with Kenyan officials to build a state-of-the-art mRNA facility, which was first announced in October 2021. The site will focus on producing up to 500 million vaccine doses a year. Source: Fierce Pharma 7/3/22